BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9014861)

  • 1. The presence of cytokines in Langerhans' cell histiocytosis.
    de Graaf JH; Tamminga RY; Dam-Meiring A; Kamps WA; Timens W
    J Pathol; 1996 Dec; 180(4):400-6. PubMed ID: 9014861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monokine expression in Langerhans' cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Foss HD; Herbst H; Araujo I; Hummel M; Berg E; Schmitt-Gräff A; Stein H
    J Pathol; 1996 May; 179(1):60-5. PubMed ID: 8691347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis.
    Kannourakis G; Abbas A
    Br J Cancer Suppl; 1994 Sep; 23():S37-40. PubMed ID: 8075004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells.
    de Graaf JH; Tamminga RY; Kamps WA; Timens W
    Am J Pathol; 1995 Oct; 147(4):1161-71. PubMed ID: 7573361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Langerhans' cell histiocytosis cells are activated Langerhans' cells.
    Emile JF; Fraitag S; Leborgne M; de Prost Y; Brousse N
    J Pathol; 1994 Oct; 174(2):71-6. PubMed ID: 7965409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerhans' cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation.
    de Graaf JH; Tamminga RY; Kamps WA; Timens W
    Am J Pathol; 1994 Mar; 144(3):466-72. PubMed ID: 7510455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?
    Garabedian L; Struyf S; Opdenakker G; Sozzani S; Van Damme J; Laureys G
    Eur Cytokine Netw; 2011 Sep; 22(3):148-53. PubMed ID: 22001902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment.
    Tazi A; Moreau J; Bergeron A; Dominique S; Hance AJ; Soler P
    J Immunol; 1999 Sep; 163(6):3511-5. PubMed ID: 10477625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.
    Egeler RM; Favara BE; van Meurs M; Laman JD; Claassen E
    Blood; 1999 Dec; 94(12):4195-201. PubMed ID: 10590064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease.
    da Costa CE; Egeler RM; Hoogeboom M; Szuhai K; Forsyth RG; Niesters M; de Krijger RR; Tazi A; Hogendoorn PC; Annels NE
    J Pathol; 2007 Jun; 212(2):188-97. PubMed ID: 17447723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis.
    Annels NE; Da Costa CE; Prins FA; Willemze A; Hogendoorn PC; Egeler RM
    J Exp Med; 2003 May; 197(10):1385-90. PubMed ID: 12743170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal monocyte-derived dendritic cell function in patients with Langerhans-cell-histiocytosis.
    Holter W; Ressmann G; Grois N; Lehner M; Parolini O; Gadner H
    Med Pediatr Oncol; 2002 Sep; 39(3):181-6. PubMed ID: 12210447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokines in children with immunodeficiencies].
    Kowalczyk D
    Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage.
    Egeler RM; van Halteren AG; Hogendoorn PC; Laman JD; Leenen PJ
    Immunol Rev; 2010 Mar; 234(1):213-32. PubMed ID: 20193021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.
    Quispel WT; Stegehuis-Kamp JA; Santos SJ; Egeler RM; van Halteren AG
    J Interferon Cytokine Res; 2015 Oct; 35(10):831-9. PubMed ID: 26381039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of Langerhans cells and Langerhans cell histiocytosis.
    Bechan GI; Egeler RM; Arceci RJ
    Int Rev Cytol; 2006; 254():1-43. PubMed ID: 17147996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages in Langerhans cell histiocytosis are differentiated toward M2 phenotype: their possible involvement in pathological processes.
    Ohnishi K; Komohara Y; Sakashita N; Iyama K; Murayama T; Takeya M
    Pathol Int; 2010 Jan; 60(1):27-34. PubMed ID: 20055949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prominent Langerhans' cell migration in the arthropod bite reactions simulating Langerhans' cell histiocytosis.
    Kim SH; Kim DH; Lee KG
    J Cutan Pathol; 2007 Dec; 34(12):899-902. PubMed ID: 18001411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of GM-CSF receptor by Langerhans' cell histiocytosis cells.
    Emile JF; Fraitag S; Andry P; Leborgne M; Lellouch-Tubiana A; Brousse N
    Virchows Arch; 1995; 427(2):125-9. PubMed ID: 7582241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter.
    McClain KL; Laud P; Wu WS; Pollack MS
    Med Pediatr Oncol; 2003 Dec; 41(6):502-7. PubMed ID: 14595706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.